Discover 201 paid clinical trials in Vermont. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Vermont offers a variety of opportunities for both healthy volunteers interested in taking part in paid studies and those with specific health conditions. Research centers in Burlington, Rutland, and Montpelier are actively recruiting, granting access to cutting-edge therapies and innovative medical care.
Filter
1
Filter results
Results: 201
Active & Responsive
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Location: Boston MA, Providence RI, Hartford CT, New Haven CT,
Sponsor: Children's Oncology Group
Sex: All
Age: 0+
Code: NCT00736749
Recruiting
Active & Responsive
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Voyage)
for
Generalized Anxiety Disorder
Location: Boston MA, Bennington VT, The Bronx NY, New York NY,
Sponsor: Definium Therapeutics US, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06741228
Phase3, Recruiting
Active & Responsive
American Lung Association (ALA) Lung Health Cohort
for
Lung Diseases
Location: Hawthorne NY, New York NY, Colchester VT,
Sponsor: Johns Hopkins University
Sex: All
Age: 25 - 35
Code: NCT04543461
Recruiting
Active & Responsive
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
for
Hypothyroidism
Location: Boston MA, Dracut MA, Nashua NH, Smithtown NY,
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT06345339
Phase2, Phase3, Recruiting
Active & Responsive
Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response
for
Primary Central Nervous System Lymphoma
Location: Burlington VT, Hershey PA, Charlottesville VA,
Sponsor: Providence Health & Services
Sex: All
Age: 18+
Code: NCT06175000
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
for
Generalized Myasthenia Gravis
Location: Burlington VT, Washington D.C. DC, Falls Church VA,
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Sex: All
Age: 18+
Code: NCT06463587
Phase3, Recruiting
Active & Responsive
IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study)